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Cytomegalovirus (HCMV) contains cholesterol, but
how HCMV interacts with host cholesterol meta-
bolism is unknown. We found that, in human fibro-
blasts, HCMV infection increased the efflux of cellular
cholesterol, despite reducing the abundance of
ABCA1. Mechanistically, viral protein US28 was
acting through CDC42, rearranging actin microfila-
ments, causing association of actin with lipid rafts,
and leading to a dramatic change in the abundance
and/or structure of lipid rafts. These changes dis-
placed ABCA1 from the cell surface but created
new binding sites for apolipoprotein A-I, resulting
in enhanced cholesterol efflux. The changes also
reduced the inflammatory response inmacrophages.
HCMV infection modified the host lipidome profile
and expression of several genes and microRNAs
involved in cholesterol metabolism. In mice, murine
CMV infection elevated plasma triglycerides but did
not affect the level and functionality of high-density
lipoprotein. Thus, HCMV, through its protein US28,
reorganizes lipid rafts and disturbs cell cholesterol
metabolism.
INTRODUCTION
Cytomegalovirus (HCMV) infection is one of the most prevalent
viral infections in humans, with up to 75% of the population
carrying the virus. In its latent form, HCMV infection is thought
to be largely asymptomatic, with only a few viral transcripts ex-
pressed. However, when reactivated, HCMV may cause severe
disease in immunocompromised individuals. Acute HCMV infec-
tion affects many tissues, including viral effects on the vascular
endothelium, leading to vascular dysfunction, bleeding, and186 Cell Reports 16, 186–200, June 28, 2016 ª 2016 The Author(s).
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morbidity or not is unclear and, considering the high prevalence
of the infection, a causative relationship is difficult to ascertain
by traditional epidemiological methods. A number of previous
studies have suggested that latent HCMV infection contributes
to the risk of atherothrombosis (Zhu et al., 1999) and cancer (So¨-
derberg-Naucle´r et al., 2013). Given that cellular and systemic
cholesterol metabolism plays a central role in the pathogenesis
of atherosclerosis and was implicated in the pathogenesis of
several malignancies (Zhuang et al., 2005), it is possible that a
connection between HCMV infection and associated diseases
involves an interaction between HCMV and host cholesterol
metabolism.
Pathogens of different taxa interact with host cholesterol
metabolism (Sviridov and Bukrinsky, 2014). A common purpose
of this interaction is, on the one hand, to facilitate formation of
plasma membrane lipid rafts or intracellular raft-like membrane
structures, which are used by pathogens as entry gates, assem-
bly platforms, and budding sites and require the presence
of abundant cholesterol. On the other hand, many pathogens
disrupt or modify rafts in order to reduce exposure to the immune
system, which interacts with infected cells via rafts (Triantafilou
et al., 2002). HCMV is an enveloped virus, and its virions contain
host-derived cholesterol (Gudleski-O’Regan et al., 2012), but
very little is known about the interaction of HCMV with host
cholesterol metabolism. Infection of endothelial and epithelial
cells and macrophages by HCMV requires receptor-mediated
endocytosis, a process that is dependent on cholesterol (Haspot
et al., 2012; Ryckman et al., 2006), and inhibition of cholesterol
biosynthesis in human endothelial cells restrained HCMV repli-
cation (Potena et al., 2004). HCMV infection was associated
with increased expression of low-density lipoprotein-related
protein (LRP1); silencing of LRP1 concomitantly increased
cellular cholesterol content and cholesterol content, as well as
the yield and infectivity of the virus (Gudleski-O’Regan et al.,
2012). HCMV-infected cells also have reduced abundance
of ABCA1, a key transporter in the cholesterol efflux pathwaycreativecommons.org/licenses/by-nc-nd/4.0/).
(Sanchez and Dong, 2010). These examples indicate a possible
dependence of HCMV replication on host cholesterol meta-
bolism, prompting us to investigate mechanisms of interaction
between the two. Here, we established that HCMV, through its
protein US28,modifies host cholesterol metabolism and restruc-
tures lipid rafts, enhancing cholesterol efflux from host cells.
RESULTS
HCMV Infection Enhances Cholesterol Efflux
To investigate the effect of HCMV infection on cholesterol efflux,
human fibroblasts were infected with HCMV strain Toledo at an
MOI of 1, and their ability to release cholesterol to lipid-free apoli-
poprotein A-I (apoA-I) was tested at 24 and 48 hr post-infection.
The duration of the efflux incubation (2 hr) was on a proportional
part of the time-dependence curve, and the concentration of
apoA-I (30 mg/ml) was close to saturation, ensuring that the con-
centration of the acceptor was not rate limiting. Labeling of cells
with cholesterol (i.e., specific radioactivity of cholesterol) was not
affected by the infection (data not shown). Figure 1A shows that
HCMV infection enhanced the rate of specific cholesterol efflux
by 4-fold and 2-fold after 24 and 48 hr, respectively. Non-specific
efflux (i.e., the efflux in the absence of an acceptor) was unaf-
fected by the infection (data not shown).
Cholesterol efflux to lipid-freeapoA-I is solelydeterminedby the
activity of the ABCA1 transporter. Therefore, we investigated
two other acceptors: isolated high-density lipoprotein (HDL),
an acceptor using ABCG1- and SR-B1-dependent pathways;
and methyl-b-cyclodextrin (MbCD), a non-specific acceptor of
cholesterol. Both acceptors were used in saturating concentra-
tions. Figure 1B shows that, after 48 hr of infection, efflux to
both apoA-I and HDL was significantly enhanced, while the efflux
to MbCD was unaffected. To further confirm that the effect of
HCMV infection isanactiveandspecificprocessand isnot related
to passive diffusion of cholesterol, we tested the efflux of choles-
terol from cells fixed with paraformaldehyde prior to the efflux in-
cubation. While the efflux from live cells to apoA-I was enhanced
after 48 hr of infection, the efflux from fixed cells was similar for in-
fected and uninfected cells (Figure 1C; note that the conditions of
this experiment were different, resulting in higher levels of efflux).
To rule out the possibility that changes in cholesterol efflux were
related to changes in cell viability, we tested the effect of HCMV
infection on necrosis (Figure 1D) and apoptosis (Figure 1E) after
24 and 48 hr of infection; neither was affected by the infection.
Finally, to ensure that the effectswere not unique to the laboratory
strain of HCMV, we tested the effects of an additional clinical
HCMV strain (Merlin). This HCMV strain also caused elevation of
cholesterol efflux to apoA-I, although the effect was less profound
(Figure 1F). Thus, HCMV infection enhanced specific cholesterol
efflux from host cells.
Involvement of Host Cholesterol Transporters
Increased cholesterol efflux to apoA-I is usually a result of
increased abundance of total and/or cell-surface ABCA1. How-
ever, when we examined the abundance of ABCA1 in cells in-
fected with HCMV, unexpectedly, we found that it was reduced
(Figure 2A). The densitometry of bands showed that the ABCA1/
GAPDH ratio was 0.7 ± 0.08 versus 0.4 ± 0.07 (mean ± SD) foruninfected versus infected cells, respectively (p < 0.003, n = 4).
Furthermore, the abundance of cell-surface ABCA1 was also
reduced in infected cells (Figure 2A). The abundance of two other
transporters responsible for the efflux to HDL, ABCG1 and
SR-B1, was unaffected by the infection (Figure 2B), despite
increased efflux to HDL in infected cells (Figure 1B). We then
stimulated the expression of ABCA1 andABCG1 by treating cells
with the LXR agonist TO901317. As expected, this treatment
increased the rate of cholesterol efflux in both infected and unin-
fected cells; however, the efflux from HCMV-infected cells was
higher at both conditions, and the absolute difference between
cholesterol efflux from infected and uninfected cells was similar
in cells treated or not treated with the LXR agonist (Figure 2C).
When ABCA1 abundance was reduced by approximately 80%
after transfecting cells with small interfering RNA (siRNA)ABCA1
(Figure 2D, inset), the efflux from uninfected cells was signifi-
cantly reduced, while the efflux from infected cells was un-
affected by ABCA1 silencing (Figure 2D). The pathway of
ABCA1-dependent cholesterol efflux also involves the efflux
of phospholipids, either simultaneously or prior to the efflux of
cholesterol (Vedhachalam et al., 2007). When we tested the
effect of HCMV infection on phospholipid efflux, no changes
were found (Figure 2E). Collectively, these findings suggest
that the increase of cholesterol efflux after HCMV infection is
not mediated by host ABCA1.
Involvement of HCMV Proteins
An alternative possibility explaining enhanced cholesterol efflux
fromcells infectedwithHCMV is that the virus introduces anaddi-
tional virus-derived efflux pathway into the host cell. To test this
possibility, we infected cells with HCMV inactivated by UV irradi-
ation. UV irradiation does not affect the capacity of the virus to
enter target cells but blocks viral gene transcription (Zhu et al.,
1997).We found that UV inactivation of the virus completely abol-
ished its capacity to stimulate cholesterol efflux (Figure 3A) and to
reduce ABCA1 abundance (Figure 3B, lanes 1, 2, and 5). Similar
effects on cholesterol efflux were demonstrated when the UV-in-
activated Merlin HCMV strain was used (data not shown). To
further confirm the requirement for active replication, we treated
cells with a specific inhibitor of HCMV DNA polymerase, phos-
phonoacetic acid (PAA) (Stinski, 1977). Treatment with PAA
had no effect on cholesterol efflux from uninfected cells but
completely abolished the increase of cholesterol efflux seen in
infected cells (Figure 3C).
HCMV is a complex virus; its genome contains more than 160
open reading frames (ORFs), and the functions of many of the
products of these genes are not known. None of the HCMV pro-
teins carries sequences homologous to known sterol-binding or
sterol-sensing domains of mammalian proteins. The HCMV pro-
tein US28 is a 41-kDa G-protein-coupled receptor expressed at
all stages of the infection and found in perinuclear endosomes
and lipid rafts (Droese et al., 2004). It was previously implicated
as potentially playing a role in the pathogenesis of atheroscle-
rosis by altering smooth muscle cell migration (Streblow et al.,
1999). We tested whether US28 may be also responsible for
the viral effects on cholesterol efflux. We compared uninfected
cells with cells infected with the Toledo strain, a DUS28 viral
mutant based on the VR1814 strain and the parental VR1814Cell Reports 16, 186–200, June 28, 2016 187
Figure 1. HCMV Enhances Cholesterol Efflux from Human Fibroblasts
(A) Time dependence of the effect of HCMV infection on cholesterol efflux to apoA-I (30 mg/ml).
(B) The effect of HCMV infection (48 hr) on cholesterol efflux to apoA-I (30 mg/ml), HDL (40 mg/ml), and methyl-b-cyclodextrin (200 mg/ml).
(C) The effect of fixing cells with paraformaldehyde (PFA) on the effect of HCMV infection (48 hr) on cholesterol efflux to apoA-I.
(D) The effect of HCMV infection (48 hr) on cell necrosis.
(E) The effect of HCMV infection (48 hr) on cell apoptosis.
(F) The effect of infection with clinical strain of HCMV (Merlin, 48 hr) on cholesterol efflux to apoA-I.
Data indicate means ± SD. *p < 0.05; **p < 0.01 (versus uninfected).strain (+US28). While infection with both Toledo and +US28
viruses similarly increased cholesterol efflux, the DUS28 virus
failed to do so (Figure 3D). When the effects on ABCA1 abun-
dance were examined, again, the +US28 virus reduced abun-
dance of ABCA1, while the DUS28 virus was less effective188 Cell Reports 16, 186–200, June 28, 2016(Figure 3B, lanes 1–4). In a complementary set of experiments,
we transiently overexpressed US28 tagged with turboGFP
(tGFP) in the host cells in the absence of the virus (Figure 3E,
inset). Overexpression of US28 resulted in an increase of the
rate of cholesterol efflux, similar to the positive control, cells
Figure 2. Involvement of Host Cholesterol Transporters in the Effects of HCMV on Cholesterol Efflux
(A) The effect of HCMV infection (48 hr) on the abundance of total (left) and cell-surface (right) ABCA1.
(B) The effect of HCMV infection (48 hr) on the abundance of ABCG1 and SR-B1.
(C) The effect of activation of expression of ABC transporters with LXR agonist TO901317 on cholesterol efflux from HCMV-infected cells (48-hr infection) to
apoA-I.
(D) The effect of silencing ABCA1 on cholesterol efflux from HCMV-infected cells (48-hr infection) to apoA-I. Inset: abundance of ABCA1 after silencing with
siRNAABCA1. siRNAs, scrambled siRNA.
(E) The effect of HCMV infection (48 hr) on phospholipid efflux to apoA-I.
Data indicate means ± SD. *p < 0.05; ***p < 0.001 (versus uninfected); #p < 0.05 (versus untreated).overexpressing ABCA1 (Figure 3E). Furthermore, overexpres-
sion of US28 in HCMV(DUS28)-infected cells elevated choles-
terol efflux even above that in cells infected with the parent
HCMV(+US28) virus (Figure 3F).When the effect of US28 overex-
pression on ABCA1 abundance was examined, the total ABCA1
abundance was unchanged in US28-transfected cells (Fig-
ure 3G). The abundance of cell-surface ABCA1 was, however,
lower in US28 versus mock-transfected cells (482 versus 662
arbitrary densitometry units [a.d.u.]), confirming that, in cellstransfected with US28, ABCA1 is located in a compartment not
exposed to the cell surface. A discrepancy between the effects
of HCMV infection andUS28 transfection on the total abundance
of ABCA1 is likely a reflection of different amounts of US28 intro-
duced by viral infection versus transfection or is temporal; how-
ever, we cannot exclude a possibility that US28 requires a
co-factor for its effects on ABCA1.
Finally, overexpression of US28 in another cell type, mouse
macrophage RAW 264.7 cells, also elevated cholesterol effluxCell Reports 16, 186–200, June 28, 2016 189
(legend on next page)
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(Figure 3H). Thus, it appears that HCMVprotein US28 is essential
and sufficient for the effects of HCMV on cholesterol efflux; it is
also essential, but may not be sufficient, for the reduction of
ABCA1 abundance in host cells.
Mechanism of the Effect of HCMV on Cholesterol Efflux
To investigate the mechanism of US28-dependent stimulation of
cholesterol efflux, we tested the effect of US28 on apoA-I binding
to host cells. Infection of cells with +US28HCMV led to an almost
3-fold elevation of apoA-I binding to cells, compared to unin-
fected cells (Figure 4A). Infection of cells with US28-deficient
HCMV virus led to a reduction of apoA-I binding, compared to
cells infected with the +US28 virus (Figure 4A). Next, we tested
the effect of overexpression of US28 on apoA-I binding. Trans-
fection of cells with US28 more than doubled the binding of
apoA-I, compared to mock-transfected cells, exceeding the ef-
fect of transfection with ABCA1 (Figure 4B). The effect of US28
on apoA-I binding was further confirmed with two independent
methods. First, the amount of apoA-I bound to mock- or
US28-transfected cells was analyzed by western blot. Repre-
sentative images of western blots of cell-bound [Alexa Fluor
647]apoA-I are shown in Figure 4C. We found that transfection
of US28 increased the apoA-I/GAPDH ratio by 1.38 (± 0.045)-
fold (n = 3) in US28- versus mock-transfected cells (p < 0.05).
Second, we used live confocal microscopy to analyze the bind-
ing of [Alexa Fluor 647]apoA-I to mock- or US28-transfected
cells. Findings are presented in Figure 4D (note that, for better
visualization, colors were changed and tGFP is presented as
red, while Alexa Fluor 647 is shown as green). The left panel in
Figure 4D shows a small amount of apoA-I (green dots) bound
to mock-transfected cells. The middle panels show apoA-I
bound to the surface of the US28-transfected cell (red) but not
to the surface of untransfected cell (seen at bright-filed picture
on the right panel). Quantitation of the confocal images demon-
strated that twice as much apoA-I binds to US28-transfected
versus mock-transfected cells (Figure 4D, right panel).
We hypothesized that the mechanism of the effect of US28 on
apoA-I binding could be a direct binding of apoA-I to US28 on the
cell surface, leading to a translocation of plasma-membrane
cholesterol to bound apoA-I. To test this hypothesis, we overex-
pressed tGFP-tagged US28 in human fibroblasts, incubated
cells with human apoA-I, cross-linked with cell-impermeable
cross-linker followed by immunoprecipitation with either anti-
apoA-I or anti-tGFP antibody. Immunoprecipitation with both
anti-tGFP and anti-apoA-I failed to detect a direct binding be-Figure 3. Involvement of Viral Proteins in the Effects of HCMV on Chol
(A) The effect of UV irradiation on the ability of HCMV (48-hr infection) to enhanc
(B) The effect of UV irradiation and of deletion of the US28 gene on the ability of
(C) The effect of phosphonoacetic acid (PAA) on the ability of HCMV (48-hr infec
(D) Cholesterol efflux to apoA-I from cells not infected with HCMV or infected w
containing US28 (HCMV(+US28)); all infections were for 48 hr.
(E) The effect of transient overexpression of tGFP-US28 or hABCA1 on cholesterol
(right) plasmid.
(F) Cholesterol efflux to apoA-I from cells infected with HCMV(+US28), HCMV
with US28.
(G) The effect of transient overexpression of tGFP-US28 on the abundance of to
(H) The effect of transient overexpression of tGFP-US28 on cholesterol efflux fro
Data indicate means ± SD. *p < 0.01; **p < 0.01; ***p < 0.001.tween US28 and apoA-I (Figure 4E). At the same time, analysis
of complexes immunoprecipitated with anti-apoA-I revealed
ample binding of apoA-I to ABCA1 (Figure 4E, right panel).
Thus, it appears unlikely that US28 closely associates with or
directly binds to apoA-I. An alternative is that HCMV, through
US28, alters the structure of plasma membrane, creating sites
where apoA-I can bind and solubilize membrane lipids, a mech-
anism recently suggested for the ABCA1-dependent cholesterol
efflux (Vedhachalam et al., 2007).
The binding of apoA-I stimulates transfer of cholesterol to the
plasma membrane and increases the abundance of cholesterol
on the cell surface (Sviridov et al., 2001). Therefore, we tested
whether HCMV infection alters the abundance of cholesterol
on the surface of plasma membrane (defined as a proportion
of cholesterol susceptible to oxidation by cholesterol oxidase).
Both HCMV infection and overexpression of US28 significantly
increased the abundance of cell-surface cholesterol (Figures
4F and 4G). This finding was further confirmed by analyzing
the amount of BODIPY-cholesterol incorporated into cell
membranes after pulse labeling of cells by incubating them
for 10 min with BODIPY-cholesterol /cyclodextrin complex.
The amount of BODIPY-cholesterol extracted from the plasma
membranes of US28-transefcted cells was twice that in the
mock-transfected cells (Figure 4H, left panel), while the abun-
dance of the membrane marker aNa+/K+ATPase (‘‘loading con-
trol,’’ analyzed using western blot in samples from the same
experiment) was slightly less (Figure 4H, middle panel). Enrich-
ment of membranes with cholesterol usually leads to increased
abundance of lipid rafts; therefore, we also analyzed the abun-
dance in the membrane fraction of the raft marker flotillin. Unex-
pectedly, the abundance of flotillin in cells transfected with US28
decreased, compared to that in mock-transfected cells (Fig-
ure 4H, right panel), when normalized to loading control (Fig-
ure 4H, middle panel). Thus, HCMV and US28 increased the
binding of apoA-I and abundance of cholesterol on the cell
surface; both factors may contribute to the increased cholesterol
efflux.
Lipid rafts are an important structural element of plasmamem-
brane involved in regulation of cholesterol efflux and many other
metabolic processes. Therefore, we further investigated the ef-
fect of US28 on the abundance of rafts using confocal micro-
scopy. Flotillin and ganglioside GM1 (assessed through binding
of cholera toxin subunit B [CT-B]) were used as raft markers,
and the experiments were conducted in two modifications: in
cell suspension, where the plasma membrane can be clearlyesterol Efflux
e cholesterol efflux to apoA-I.
HCMV (48-hr infection) to reduce abundance of ABCA1.
tion) to enhance cholesterol efflux to apoA-I.
ith wild-type (WT) HCMV, HCMV(DUS28), and parent virus to HCMVDUS28
efflux. Inset: presence of US28 after transfection withmock (left) or tGFP-US28
(DUS28), or HCMVDUS28 (48-hr infection) in combination with transfection
tal (top left) or cell-surface (right) ABCA1.
m RAW 264.7 cells.
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Figure 4. Mechanism of the Effect of HCMV on Cholesterol Efflux
(A) The effect of HCMV(+US28) and HCMV(DUS28) (48-hr infection) on binding of apoA-I to human fibroblasts.
(B) The effect of overexpression of US28 or ABCA1 on apoA-I binding (2 hr) to human fibroblasts.
(legend continued on next page)
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visualized, and in adherent cells, a more natural state for fibro-
blasts. In suspended fibroblasts transfected with mock-GFP
plasmid, we found a high abundance of flotillin- and GM1-posi-
tive staining on the plasma membrane, consistent with a high
abundance of rafts in these cells (Figure 5A). In cells transfected
with US28-tGFP, two types of staining were observed. In some
transfected cells, US28 was localized to the nucleus, cytoplasm,
and plasma membrane; in these cells, we observed weaker
staining with anti-flotillin antibody but clearly distinguishable
staining of the plasma membrane with CT-B (Figure 5B). In other
cells, US28 localized to the perinuclear space and nucleus; in
these cells, no flotillin- or GM1-positive staining was observed
on plasma membrane (Figure 5C). Quantitation of flotillin abun-
dance derived from confocal microscopy experiments is shown
in Figure 5D. Similar observations weremade with adherent cells
(Figure S1A). Two types of intracellular distribution of US28 were
reported previously and are thought to reflect temporal regula-
tion, with nucleus-localized US28 representing later stages of
infection (Noriega et al., 2014). We further confirmed these find-
ings in cells infected with +US28 and DUS28 HCMV. While, in
uninfected cells, we observed an abundant and even staining
of plasma membrane with anti-flotillin antibody and CT-B (Fig-
ure 5E), in cells infected with +US28 virus, the abundance of flo-
tillin and GM1 was considerably reduced and became uneven
(‘‘clustered’’) (Figure 5F). Abundance and distribution of raft
markers in cells infectedwithDUS28HCMVwere similar to those
in uninfected cells (Figure 5G), while infection with DUS28
virus combined with transfection with US28-tGFP again led to
reduced abundance and clustering of lipid raft markers (Fig-
ure 5H; cells transfected with US28-tGFP are identified by
tGFP fluorescence). Quantitation of flotillin abundance derived
from confocal microscopy experiments is shown in Figure 5I.
Similar observations weremadewith adherent cells (Figure S1B).
Thus, HCMV infection and transfectionwith US28 reduced abun-
dance of rafts and/or severely affected their properties, inducing
clustering and exclusion of key lipid raft markers.
To understand amechanism responsible for re-organization of
lipid rafts by HCMV, we investigated the status of actin cytoskel-
eton in infected cells. Actin microfilaments are involved in main-
taining the structure of rafts, including their clustering (Chichili
and Rodgers, 2007), and are responsible for the alteration of
raft structure by the influenza virus (Simpson-Holley et al.,
2002). Indeed, actin cytoskeleton was altered in HCMV-infected
cells showing considerable rearrangement; we also observed
the co-localization of actin with GM1 in the sites of raft clustering(C) Western blot of [Alexa Fluor 647]apoA-I bound to mock- or US28-transfected
(D) Live confocal microscopy images of [Alexa Fluor 647]apoA-I bound to moc
changed, and GFP is presented as red, while Alexa Fluor 647 is shown as gre
fluorescent (left middle panel) and bright-field (right middle panel) images of U
transfected and mock-transfected cells. Scale bars, 10 mm.
(E) Cross-linking of apoA-I with tGFP-US28 or ABCA1 in cells overexpressing tG
whether cells were transfected with mock (M) or US28 plasmid; middle row spec
antibody used for visualization of the bands.
(F) The effect of HCMV infection (48 hr) on the abundance of cell-surface choles
(G) The effect of overexpression of US28 on the abundance of cell-surface chole
cholesterol into plasma membrane. Left panel: fluorescence of BODIPY-choleste
abundance of aNa+/K+ATPase in the same samples analyzed by western blot; rig
Data indicate means ± SD. *p < 0.05; **p < 0.01; ***p < 0.001.(Figures 6A and 6B). Similar changes in actin cytoskeleton and
increased co-localization of actin with GM1 was observed in
US28-transfected cells when compared to mock-transfected
cells (Figures 6C and 6D; note that the color of GFPwas changed
to blue to identify transfected cells).
US28 is known to initiate a signaling cascade, resulting in the
activation of CDC42 (Melnychuk et al., 2004; Vischer et al.,
2014), a small GTPase of the Rho family implicated in the regula-
tion of actin polymerization (Chadda et al., 2007; Vischer et al.,
2014). To test whether this mechanism is involved, we silenced
CDC42 in human fibroblasts, using siRNACDC42. Silencing of
CDC42 resulted inapproximately 80%reductionofCDC42abun-
dance (Figure 6E). When the binding of [Alexa Fluor 647]apoA-I
was tested in cells transfected with scrambled siRNA, as
expected, co-transfection with US28 increased apoA-I binding
(Figure 6F, lanes 1 and 2). When cells were transfected with
siRNACDC42, the increase of apoA-I binding in US28-transfected
cells was completely eliminated (Figure 6F, lanes 3 and 4). This
finding was confirmed by measuring the effects of US28 on
cholesterol efflux from cells after CDC42 silencing: silencing of
CDC42 completely eliminated the increase of cholesterol efflux
caused by US28 transfection (Figure 6G). Thus, a mechanism
of the effects of HCMV on the structure of lipid rafts is through
CDC42-mediated remodeling of actin cytoskeleton.
Effect of US28 on Inflammation
Changes in lipid rafts may lead to impairment of multiple
signaling pathways, including inflammatory cytokine production.
Therefore, we investigated possible physiological implications of
the effects of US28 and tested whether overexpression of US28
affects elements of inflammation. Mouse macrophage RAW
264.7 cells were transfected either with mock plasmid or with
US28, and cytokine secretionwas analyzed. Transfection of cells
with US28 significantly reduced unstimulated secretion of inter-
leukin (IL)-6, IL-27, and interferon (IFN)-b (Figure S2A). When
cells were stimulated with lipopolysaccharide (LPS), secretion
of IL-6, IL-27, and granulocyte/macrophage colony-stimulating
factor (GM-CSF) was reduced in cells transfected with US28
(Figure 6H, solid bars). To assess the contribution of US28-medi-
ated raft modifications to cytokine secretion, we compared
the effects of transfecting cells with US28 with the effects of
MbCD, which modifies rafts by extracting cholesterol and does
not interact with known chemokine receptors. Treatment of cells
with MbCD reduced the abundance of rafts (Figure S2B) and
significantly reduced LPS-stimulated secretion of IL-6 andcells. MW, molecular weight.
k- or US28-transfected cells. Note that, for better visualization, colors were
en. Left panel: fluorescence image of mock-transfected cell. Middle panels:
S28-transfected cells. Right panel: quantitation of apoA-I binding to US28-
FP-US28. The table below the panel explains the conditions: top row specifies
ifies the antibody used for immunoprecipitation (IP); bottom row specifies the
terol.
sterol. (H) The effect of overexpression of US28 on incorporation of BODIPY-
rol bands after separation of membrane lipid extract using TLC; middle panel:
ht panel: abundance of flotillin in the same samples analyzed by western blot.
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Figure 5. The Effect of HCMV on Lipid Rafts
(A) The effect of transfection of fibroblasts with mock-GFP on the abundance of flotillin and GM1.
(B) The effect of transfection of fibroblasts with US28-tGFP on the abundance of flotillin and GM1 when US28 is distributed to cytoplasm.
(C) The effect of transfection of fibroblasts with US28-tGFP on the abundance of flotillin and GM1 when US28 is distributed to the nucleus.
(D) Quantitation of flotillin abundance derived from confocal microscopy experiments. CTCF, corrected total cell fluorescence. **p < 0.01; ***p < 0.001 (versus
mock-GFP or as shown). Cyto., cytoplasm; Nucl., nucleus.
(E) Abundance and distribution of flotillin and GM1 in uninfected cells.
(F) The effect of infection of fibroblasts with HCMV(+US28) (48 hr) on the abundance and distribution of flotillin and GM1.
(legend continued on next page)
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GM-CSF, similar to the effects of transfection with US28 (Fig-
ure 6H). However, the effect of MbCD on LPS-stimulated secre-
tion of IL-27 was opposite that of US28, indicating the possible
contribution of chemokine scavenging and receptor hijacking,
previously attributed to US28 (Vischer et al., 2014), to its anti-in-
flammatory properties. When conditioned medium from US28-
transfected macrophages (not stimulated with LPS) was added
to the endothelial cells carrying reporter gene under the control
of VCAM-1 promoter, we observed a 25% reduction in the stim-
ulatory effect on VCAM1 expression, when compared with
medium from mock-transfected cells (Figure 6I).
Effect of HCMV Infection on Cellular Lipid Metabolism
Our findings imply that HCMV infection replaces the cell-specific
ABCA1-dependent pathway of cholesterol efflux with a virus-
specific US28-dependent cholesterol efflux. To elucidate the
net effect of such substitution on lipid content, we performed
lipidomic analysis of cells infected with HCMV. The findings
are summarized in Figure 7A, with a full dataset presented in
Table S1. The notable effects of HCMV infection on cellular lipids
were small, but statistically significant, elevations of the abun-
dance of ceramide, dihexosylceramide, and GM3 ganglioside.
These lipids play an important role in maintaining the structure
and functional properties of lipid rafts (Quinn, 2014). Total abun-
dance of two other important components of rafts, cholesterol
and sphingomyelin, were not affected by the infection; abun-
dance of cholesteryl esters was also unaffected.
Cholesterol efflux is often non-productive: the release of
cellular cholesterol to extracellular acceptor may be compen-
sated by cholesterol uptake, with no net change in overall cellular
cholesterol content. We further investigated this issue and
measured two surrogate markers of cellular cholesterol content:
rates of cholesterol biosynthesis and esterification. The rate
of cholesterol biosynthesis in HCMV-infected (Figure 7B) or
US28-transfected (Figure 7C) cells was slightly reduced, while
the rate of cholesterol esterification was increased (Figures 7D
and 7E) compared to that in uninfected cells. These findings
are consistent with an increased, rather than decreased, abun-
dance of cholesterol, at least in the regulatory pool in the endo-
plasmic reticulum. HCMV infection also caused a modest
increase in the incorporation of [3H]acetate into free fatty acids
(1.26 ± 0.04 versus 1.09 ± 0.08 dpm per milligram or cell protein;
p < 0.05) and phospholipids (2.89 ± 0.16 versus 2.59 ± 0.08 dpm
per milligram of cell protein; p < 0.05) and had no effect on tri-
glyceride (TG) biosynthesis. When we measured the abundance
of total cellular cholesterol and cholesteryl esters in cells trans-
fected with US28, it was similar to that in mock-transfected cells
(Figure 7F), analogous to the effect of HCMV infection. Thus,
elevation of cholesterol efflux by HCMV infection or US28 trans-
fection does not appear to be productive and did not lead to
reduction of cellular cholesterol content. It might, however,
lead to a redistribution of cholesterol between cellular pools.(G) The effect of infection of fibroblasts with HCMV(DUS28) (48 hr) on the abund
(H) The effect of infection of fibroblasts with HCMV(DUS28) (48 hr) and transfect
(I) Quantitation of flotillin abundance derived from confocal microscopy experimen
or as shown).
Data indicate means ± SD. Scale bars, 10 mm. See also Figure S1.Next, we investigated the effect of HCMV infection on the
expression of lipid metabolism-related genes in host cells. We
found that the expression of MSR1, ABCA3, and ABCG1 was
increased, while the expression of ABCA12 was reduced, and
the expression of ABCA1 was unaffected (Figure S3A). Interest-
ingly, the increase in the expression of ABCG1, ABCA3, and
MSR1 in the infected cells was not translated into an increased
abundance of these proteins (Figure 2B; Figure S3B).
Next, we investigated the effect of HCMV infection on
the abundance of ten microRNAs (miRNAs) known to target
ABCA1 and cholesterol efflux in various cells (for a review, see
Canfra´n-Duque et al., 2014). Abundance of two miRNAs,
miR10b andmiR106b, was significantly elevated in infected cells
(Figure 7G), pointing to a possible mechanism of reduction
of ABCA1 abundance in cells infected with HCMV. However,
the abundance of two other miRNAs known to target ABCA1,
miR145 and miR27a, was reduced by HCMV infection. Other
miRNAs were unaffected. It must be noted that the abundance
of the affected miRNAs was low, compared to that of the main
miRNA regulator of ABCA1, miR33a (Figure S3C). The abun-
dance of miR33a and miR33b was unaffected.
Animal Studies
Finally, we analyzed the effect of CMV infection on lipid meta-
bolism in vivo using a murine model. BALB/c mice were infected
intraperitoneally with 1.8 3 106 plaque-forming units (PFUs) of
murine CMV (MCMV). It should be noted that MCMV does not
express US28 (Beisser et al., 2008). At 3 weeks post-infection,
uninfected and infected animals were euthanized. Analysis of
plasma lipoproteins (Figures S4A–S4D) revealed that MCMV
infection caused modest elevation of total plasma cholesterol,
which was mostly due to the elevation of non-HDL cholesterol.
There was a significant elevation of plasma TG content; HDL
cholesterol was unaffected. We also analyzed the capacity of
mouse plasma to support cholesterol efflux from uninfected
mouse macrophages (RAW 264.7). No effect was found (Fig-
ure S4E). Furthermore, we analyzed the effect ofMCMV infection
on the expression of genes related to cholesterol metabolism in
the liver (Figure S4F). The livers of MCMV-infected animals had
elevated expression of Abca3, similar to the in vitro findings
with HCMV, and also of Hmgcr and Lxra. Next, we analyzed
the abundance of Abca1 and Abcg1 in the liver (Figures S4G
and S4H). There was a tendency for lower abundance of
Abca1 in the liver of the infected animals, but the difference
did not reach statistical significance. However, there was statis-
tically significant elevation of the abundance of Abcg1 in the
livers of the infected animals.
DISCUSSION
Very little is known about the role of cholesterol in the life cycle
of HCMV; however, the presence of cholesterol in HCMV virionsance and distribution of flotillin and GM1.
ion with US28-tGFP on the abundance and distribution of flotillin and GM1.
ts. CTCF, corrected total cell fluorescence. *p < 0.05; **p < 0.01 (versus -HCMV
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Figure 6. Mechanism and Consequences of the Effect of HCMV on Lipid Rafts
(A and B) The effect of infection of fibroblasts with HCMV on the abundance and co-localization of GM1 and b-actin. Scale bars, 20 mm.
(C andD) The effect of transfection of fibroblasts with US28 on the abundance and co-localization of GM1 and b-actin. Note that the color of tGFPwas changed to
blue to identify transfected cells. Scale bars, 20 mm.
(legend continued on next page)
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suggests a possible interaction of the virus with cellular choles-
terol metabolism. Given the important role that such interaction
plays in the pathogenesis of many viral infections (Sviridov and
Bukrinsky, 2014), we comprehensively investigated the interac-
tion between HCMV infection and host cholesterol metabolism
in vitro and in vivo.
The main finding of this study is that HCMV restructures lipid
rafts in the host cells, causing increased cholesterol efflux and,
at the same time, reducing abundance of a key transporter in
the host cholesterol efflux pathway, ABCA1. The viral protein
responsible for this effect is US28. Mechanistically, the following
sequence of events is proposed (Figure S5): (1) US28 is acting
as chemokine receptor and activates CDC42; (2) activation
of CDC42 leads to rearrangement of actin microfilaments,
including tight association of actin with rafts; (3) remodeling of
actin affects abundance and/or structure of lipid rafts, causing
raft clustering; (4) changes in lipid rafts lead to creation of plasma
membrane regions that are capable of binding apoA-I and
releasing cholesterol (this also leads to displacement of ABCA1
from the cell surface); (5) increased binding of apoA-I causes
redistribution of intracellular cholesterol to the plasma mem-
brane; (6) elevated binding of apoA-I and an increased amount
of accessible cholesterol enhanced cholesterol efflux. Our find-
ings are consistent with the hypothesis that US28 causes a
re-distribution of cholesterol between cellular compartments,
reorganizes lipid rafts, and increases thenumber of plasmamem-
brane structures capable of binding apoA-I and releasing choles-
terol. The current understanding of themechanism of cholesterol
efflux is that ABCA1changesproperties of theplasmamembrane
domains, forming apoA-I binding sites leading to the efflux (Ved-
hachalam et al., 2007). It appears that US28 induces similar
changes to the plasma membrane without ABCA1.
US28 is a virus-encoded G-protein-coupled receptor; it is ex-
pressed in both acute and latent infection (Vischer et al., 2007)
and is only found in primate CMVs (Beisser et al., 2008). US28
affects multiple signaling pathways; it is dispensable for viral
replication, but it plays a key role in immune evasion as well as
in inflammatory and proliferative responses of the infected cells
ensuring persistence of the infection (for a review, see Beisser
et al., 2008; Vischer et al., 2007, 2014). US28was also implicated
in the pathogenesis of atherosclerosis, mainly through the ef-
fects on inflammation and migration of smooth muscle cells
and macrophages (Streblow et al., 1999; Vischer et al., 2014).
Findings of this study may provide a mechanistic explanation
for the effects of US28 on inflammatory and proliferative
signaling pathways originating from lipid rafts. Dysregulation of
cellular cholesterol metabolism inflicted by US28may contribute
to the pathogenesis of atherosclerosis through changes in abun-(E) Western blot of CDC42 with and without siRNA silencing. MW, molecular we
(F) Western blot of [Alexa Fluor 647]apoA-I bound to cells transfected with: mo
siRNACDC42 (line 3), or US28 and siRNACDC42 (line 4).
(G) Cholesterol efflux to apoA-I (30 mg/ml) from cells transfected with various co
(H) The effects of transfection with US28 or treatment with methyl-b-cyclodextrin
with LPS. Ratios of LPS-stimulated changes in US28 transfected versusmock-tran
are shown (means ± SD, n = 4).
(I) The effect of conditioned medium from RAW 264.7 cells transfected with US2
Data indicate means ± SD. *p < 0.05; **p < 0.01; ***p < 0.001 (versus mock-trandance and/or properties of cholesterol-rich plasma membrane
domains, rafts, and caveolae (Murphy et al., 2008).
Our findings raise the following question: given that expression
of US28 is not essential for HCMV replication (Vischer et al.,
2007), what advantage is gained by HCMV from enhancing
cholesterol efflux, apparently with no net effect on cellular
cholesterol content? We propose that this effect is related to
the dramatic changes in the abundance and properties of lipid
rafts. Lipid rafts are essential for many intracellular pathogens.
On the one hand, many viruses use host plasma membrane rafts
as an assembly platform, entry gate, or binding sites during cell-
to-cell transmission (Sviridov and Bukrinsky, 2014); this requires
an increased abundance of rafts. It is not currently known how
and whether HCMV interacts with rafts at different stages of its
life cycle. Juckem et al. (2008) suggested that cholesterol deple-
tion and disruption of lipid rafts result in a block of HCMV infec-
tion of fibroblasts. Infection of this cell type takes place by fusion
of the virus envelope with the plasma membrane, but whether
rafts are also essential for entry into other cell types is unknown.
On the other hand, rafts are a structural platform for innate im-
mune response (Fessler and Parks, 2011), and pathogens often
target rafts to reduce immune-related signaling originating from
rafts and exposure of infection-related factors to the immune
system; this requires a reduced abundance of rafts. To accom-
modate these two seemingly contradictory requirements, patho-
gens modify rafts. Often, they do so by modifying lipid fluxes
(Sviridov and Bukrinsky, 2014), as even small changes in lipid
flux affect raft structural properties, severely impairing signaling
from Toll-like receptors (TLRs) (Fessler and Parks, 2011).
A frequent form of raft modification is clustering, when rafts con-
verted into more stable and larger structures (Sviridov and Buk-
rinsky, 2014). We propose that HCMV, through the suggested
mechanism, changes structural and functional properties of lipid
rafts, enhancing cholesterol efflux and impairing innate immune
responses. This suggestion is supported by our finding that
transfection of mouse macrophage cells with US28 reduced
secretion of several cytokines measured both directly and by a
functional assay assessing the effects of secreted cytokines on
VCAM1 expression in endothelial cells. It is also consistent
with the ability of HCMV to inhibit IFN-a-stimulated responses,
which are known to rely on intact rafts (Miller et al., 1999).
Furthermore, we also found elevated levels of ceramide in
HCMV-infected cells; enrichment of rafts with ceramide is known
to be associated with altered transmembrane signaling and for-
mation of larger domains (Cremesti et al., 2002). However, the
suggestion of a physiological role of US28 as a modulator of
innate immunity remains speculative and needs to be tested
in an animal model—a complex task, given that only primateight.
ck plasmid and siRNAs (line 1), US28 and siRNAs (line 2), mock plasmid and
mbinations of mock and US28 plasmids, siRNAs, and siRNACDC42.
(MbCD) on cytokine secretion from RAW 264.7 macrophages after stimulation
sfected cells (filled bars) orMbCD-treated versus untreated cells (dashed bars)
8 on VCAM1 expression in mouse endothelial cells.
sfected cells); ###p < 0.001 (versus untreated cells). See also Figure S2.
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Figure 7. The Effect of HCMV Infection on Host Lipid Metabolism
(A) The effects of HCMV infection (48 hr) on abundance of cellular lipids (standardized to PC). LPC(O), alkyllysophosphatidylcholine; PG, phosphatidylglycerol;
LPE, lysophosphatidylethanolamine; LPI, lysophosphatidylinositol; LPC, lysophosphatidylcholine; DHC, dihexosylceramide; PE(O), alkylphosphatidylethanol-
amine; Cer, ceramide; THC, trihexosylceramide; MHC, monohexosylceramide; PE(P), alkenylphosphatidylethanolamine; PC(P), alkenylphosphatidylcholine;
PC(O), alkylphosphatidylcholine; GM3, GM3 ganglioside; CE, cholesteryl ester; SM, sphingomyelin; PS, phosphatidylserine; PI, phosphatidylinositol; PE,
phosphatidylethanolamine; Chol, cholesterol; PC, phosphatidylcholine.
(legend continued on next page)
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CMVs contain US28. The effects of US28 on host cholesterol
metabolism may also be related to a known capacity of HCMV
to facilitate co-infection with other viruses, including HIV, which
also critically depends on rafts and suppression of ABCA1 for
their infectivity (Cui et al., 2012). While our findings are consistent
with these hypotheses, critical evidence to support them beyond
speculation awaits further experiments.
In a mouse model, MCMV infection did not affect liver abun-
dance of Abca1, while slightly increasing plasma TG and non-
HDL cholesterol content. Animal models, however, have limita-
tions in reproducing properties of HCMV infection. Specifically,
MCMVdoes not have a gene for US28, and its chemokine recep-
tor functions are fulfilled by M33 (Beisser et al., 2008); the two
proteins have limited homology (64%), and M33 may not share
US28 functionality in modifying host cholesterol metabolism.
In conclusion, HCMV, through its protein US28, modifies
plasmamembrane rafts and enhances cholesterol efflux from in-
fected cells. Given the role of cholesterol and lipid rafts in cell
metabolism and immunity, the findings of this study may have
significant implications on understanding of the pathogenesis
of HCMV infection and its complications and may also identify
therapeutic targets for treating HCMV infection.
EXPERIMENTAL PROCEDURES
Detailed methodology is provided as Supplemental Experimental Procedures.
Virus and Cells
The low-passage Toledo strain of HCMVwas used unless indicated otherwise.
When indicated, HCMV strain VR1814 was used as the basis for deletion of the
US28 open reading frame. A clinical strain of HCMV (Merlin) was used in the
experiments described in Figure 1F.
Human foreskin fibroblast cells (HFFs) were used in the experiment
described in this study, unless indicated otherwise. HFFs were infected with
HCMV at an MOI of 1. Unless indicated otherwise, the experiments were con-
ducted 48 hr after infection. In the experiments described in Figures 3H, 6H,
and S2, RAW 264.7 mouse macrophages were used.
Cholesterol and Phospholipid Efflux
Cholesterol or phospholipids were labeled by incubation with 1 mCi of [3H]
cholesterol or [3H]choline, respectively, and cells were equilibrated and incu-
bated for 2 hr with either human apoA-I (30 mg/ml) or isolated human HDL
(40 mg/ml) or methyl-b-cyclodextrin (200 mg/ml). Efflux was expressed as a
percentage of cholesterol moved from cell to medium.
Other Techniques
Cell-surface ABCA1 was assessed after biotinylation of cell-surface proteins
(Cui et al., 2012).
To assess apoA-I binding, apoA-I was fluorescently labeled with Alexa Fluor
647 carboxyl succinimidyl ester. Cells were incubated with 20 mg/ml fluores-
cent apoA-I for 2 hr and harvested, and fluorescence was measured. Alterna-
tively, live cells were observed with confocal microscopy or lysed with RIPA
buffer and processed for LI-COR western blot.(B) The effect of HCMV infection (48 hr) on the incorporation of [3H]acetate into c
(C) The effect of transfection with US28 on the incorporation of [3H]acetate into c
(D) The effect of HCMV infection (48 hr) on the incorporation of [14C]oleic acid in
(E) The effect of transfection with US28 on the incorporation of [14C]oleic acid in
(F) The effect of transfection of cells with US28 on the abundance of total choles
(G) The effect of HCMV infection (48 hr) on the abundance of selected miRNAs r
Data indicate means ± SD. *p < 0.05; **p < 0.01; ***p < 0.001, versus control (
comparisons using the Benjamini-Hochberg method). See also Figure S3 and TaLipid biosynthesis was assessed by the incorporation of [3H]acetate into
cholesterol, free fatty acids, and TGs and phospholipids and by the incorpora-
tion of [14C]oleic acid into cholesteryl esters.
Abundance of cell-surface cholesterol on the plasma membrane was as-
sessed through susceptibility to cholesterol oxidase, as described previously
(Cui et al., 2012). Alternatively, cells were labeled with BODIPY-cholesterol/
methyl-b-cyclodextrin inclusion complex (0.17 mg/ml) at 37C for 10 min,
andmembranes were isolated as described previously (Cui et al., 2012). Lipids
were extracted from the membrane pellet, and cholesterol was separated
using TLC.
The abundance of lipid rafts was assessed using the Vybrant Lipid Rafts
Labeling Kit (Life Technologies).
Concentrations of cytokines were determined using the LEGENDplex Multi-
Analyte Flow Assay Kit (BioLegend). SVEC4/VCAM-1 cells were used to
assess the effect of secreted cytokines on VCAM-1 expression (D’Souza
et al., 2010).
MCMV Infection of Mice
Animal experiments were carried out in accordance with the Declaration of
Helsinki; the experimental protocol was approved by the ethical committee
ofWarsawMedical University (#93/2013). BALB/cmicewere infected intraper-
itoneally with 1.83 106 PFU of MCMV (Smith strain); plasma and liver samples
were collected 3 weeks post-infection.
Statistics
All data are shown as means ± SD, unless stated otherwise. Statistical signif-
icance of the differences was assessed by Student’s t test when data followed
normal distribution or Mann-Whitney U test on ranks.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.05.070.
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